Financials
Income statement
| Fiscal date | Mar 2025 | Mar 2024 | Sep 2023 | Dec 2022 |
|---|---|---|---|---|
| Total reported revenue | — | — | 2.9B | 6.2B |
| Cost of revenue | — | — | 2.2B | 5.6B |
| Gross profit | — | — | 732M | 584M |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | — | — | 46M | 202M |
| Operating income | — | — | 241M | 120M |
| Non operating interest income | ||||
| Income | — | — | 25M | -8M |
| Expense | — | — | 77M | 13M |
| Other income expense | — | — | — | — |
| Pretax income | — | — | 200M | 103M |
| Tax provision | — | — | 55M | 136M |
| Net income | — | — | 146M | -43M |
| Basic EPS | 0.1 | 0.1 | — | — |
| Diluted EPS | 0.1 | 0.1 | — | — |
| Basic average shares | 3.1B | 3.1B | — | — |
| Diluted average shares | 3.1B | 3.1B | — | — |
| EBITDA | — | — | 573M | 295M |
| Net income from continuing op. | — | — | 146M | -43M |
| Minority interests | — | — | -1M | -17M |
| Preferred stock dividends | — | — | 0 | 0 |